Results 11 to 20 of about 5,426 (198)
Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study. [PDF]
Aim To assess the efficacy and safety of repeat abobotulinumtoxinA injections in reducing upper limb spasticity in children with cerebral palsy (CP). Method This was a double‐blind, repeat‐cycle study (NCT02106351) in children with CP (2–17y). Children were randomized to receive 2U/kg (control), 8U/kg, or 16U/kg abobotulinumtoxinA injections into the ...
Delgado MR +11 more
europepmc +2 more sources
Upper limb impairments, process skills, and outcome in children with unilateral cerebral palsy. [PDF]
Aim To examine the relationships between upper limb impairments and independence in self‐care (ISC) in children with unilateral cerebral palsy (CP). Method One hundred and eight children with unilateral CP (46 females, 62 males; mean age 8y 7mo, SD 3y 9mo) recruited from a population register were assessed for upper limb muscle power, spasticity ...
Russo RN +3 more
europepmc +2 more sources
Estado nutricional de niños y niñas con parálisis cerebral que asisten a centros de rehabilitación
Objetivo Describir el estado nutricional de niños con parálisis cerebral (PC) en centros de rehabilitación y terapéuticos de Argentina, y analizar el riesgo de desnutrición en relación su nivel según el sistema de la clasificación de la función motora gruesa (GMFCS).
María de las Mercedes Ruiz Brunner +4 more
wiley +1 more source
Aim To assess the efficacy, safety, and tolerability of oromucosal nabiximols cannabinoid medicine as adjunct therapy for children with spasticity due to cerebral palsy/traumatic central nervous system injury with inadequate response to existing treatment.
Charlie Fairhurst +4 more
wiley +1 more source
Efecto neuroprotector de los cannabinoides en las enfermedades neurodegenerativas [PDF]
Se analiza la situación actual de las investigaciones relacionadas con las sustancias cannabinoides, así como su interacción con el organismo, clasificación, efectos terapéuticos y su uso en las enfermedades ...
Holgado Villafuerte, María Ángeles +2 more
core +3 more sources
Estímulo vibracional na espasticidade
A espasticidade é um distúrbio neurológico proveniente da lesão de um neurônio motor superior e da desorganização dos circuitos neurais da medula espinhal, que acarreta alterações sensório-motoras de graduações variadas. Técnicas farmacológicas, fisioterápicas e cirúrgicas são utilizadas para reduzir a espasticidade.
Eddy Krueger Beck +2 more
openaire +2 more sources
Introducción: la parálisis cerebral infantil es la causa más frecuente de discapacidad motora durante la niñez. La toxina botulínica tipo A es considerada una de las principales opciones de tratamiento para las enfermedades neurológicas que cursan con ...
Yanet Figueroa Ferrer +2 more
doaj
Tratamento medicamentoso da espasticidade
Spasticity is defined as a disorder in muscular tonus, characterized by an increase in stretching tonic-dependent reflex of velocity of movement. For its treatment almost all applied drugs show effectiveness, although there is no oral medication universally accepted. Oral drug treatment employed in the treatment of spasticyti is discussed with.
Carlos Umberto Pereira +2 more
openaire +1 more source
Masculino de 58 años, con antecedentes de Diabetes Mellitus e Hipertensión Arterial, quienconsultó por cuadro subagudo de cervicalgia yparestesias en miembros superiores. Posteriormente se complicó con síndrome medular cervical.
Diego Avila Sánchez +1 more
doaj +1 more source
Tratamento cirúrgico da espasticidade
A espasticidade decorre de uma reorganização funcional de circuitos, em geral, medulares espinais após uma lesão que afeta total ou parcialmente as vias moduladoras damotricidade e controle das interações sensitivas. Agrava-se devido a estímulos nociceptivos ou sensitivos de outra natureza, aumento de citocinas e emoções.
Manoel Jacobsen Teixeira +1 more
openaire +1 more source

